Sarah Cannon Research Institute / Tennessee Oncology — Nashville, Tennessee

Sarah Cannon Research Institute / Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute / Tennessee Oncology has participated in 15 clinical trials with 8 currently active.

Therapeutic areas: Advanced Liver Cancers, Breast Cancer, Metastatic Breast Cancer.

Sponsors: Hoffmann-La Roche, Stemline Therapeutics, Inc., Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute / Tennessee Oncology?

Sarah Cannon Research Institute / Tennessee Oncology has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute / Tennessee Oncology conducted?

Sarah Cannon Research Institute / Tennessee Oncology has 15 clinical trials on record, with 8 currently active. Their work covers Advanced Liver Cancers, Breast Cancer, Metastatic Breast Cancer.

Is Sarah Cannon Research Institute / Tennessee Oncology accredited by Crixeo Health?

Yes — Sarah Cannon Research Institute / Tennessee Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon Research Institute / Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.